DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DOPEXAMINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DOPEXAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
0VN909S60Y
Molecule Type:
Small molecule
Molecular Formula:
C22H34Cl2N2O2
Molecular Weight:
429.43
AlogP:
3.62
PSA:
64.52
HBD:
4.0
HBA:
#RotB:
13.0
Source:
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
4
Combination
Approved
GASTROINTESTINAL
INTRAVENOUS
Unknown
Unknown
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARTEMETHER; LUMEFANTRINE
4
Combination
Approved
IMMUNE SYSTEM
ORAL
Unknown
Unknown
ARTEMETHER; LUMEFANTRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RIMITEROL HYDROBROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
RIMITEROL HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
I29DRR8S3R
Molecule Type:
Small molecule
Molecular Formula:
C12H18BrNO3
Molecular Weight:
304.18
AlogP:
1.27
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
2.0
Source:
REVIPARIN SODIUM
4
Oligosaccharide
Approved
Unknown
Unknown
Thrombosis
Unknown
REVIPARIN SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
5XQ9UBJ16W
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
4
Combination
Approved
GASTROINTESTINAL
ORAL
Unknown
Unknown
SODIUM PHOSPHATE, DIBASIC ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORAMPHENICOL; PREDNISOLONE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
CHLORAMPHENICOL; PREDNISOLONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EICOSAPENTAENOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
EICOSAPENTAENOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENOTEROL
4
Small molecule
Approved
Unknown
Unknown
Heart Failure; Asthma; Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
FENOTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
22M9P70OQ9
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO4
Molecular Weight:
303.36
AlogP:
2.06
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
6.0
Source:
TECHNETIUM TC-99M ALBUMIN COLLOID KIT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC-99M ALBUMIN COLLOID KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YELLOW FEVER VACCINE
4
Unknown
Approved
Unknown
Unknown
Dermatitis, Atopic; Fever; Malaria
Unknown
YELLOW FEVER VACCINE
×
Maximum Phase:
4
First Approval:
None
UNII:
PY4EET359T
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULFUR
4
Small molecule
Approved
OTHER
TOPICAL
Unknown
Unknown
SULFUR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MALT EXTRACT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MALT EXTRACT
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SULFIRAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SULFIRAM
×
Maximum Phase:
4
First Approval:
None
UNII:
1XHL4Q8P7Y
Molecule Type:
Small molecule
Molecular Formula:
C10H20N2S3
Molecular Weight:
264.49
AlogP:
2.97
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
METADOXINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
METADOXINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDOBUFEN
4
Small molecule
Approved
Unknown
Unknown
Atrial Fibrillation; Thrombosis
Unknown
INDOBUFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
6T9949G4LZ
Molecule Type:
Small molecule
Molecular Formula:
C18H17NO3
Molecular Weight:
295.34
AlogP:
3.43
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
4.0
Source:
HYLAN G-F 20
4
Unknown
Approved
Unknown
Unknown
Patellofemoral Pain Syndrome; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee
Lubricant and shock absorber
HYLAN G-F 20
×
Maximum Phase:
4
First Approval:
None
UNII:
01OUW6MA4L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
4
Combination
Approved
OTHER
INTRAVENOUS; IV (INFUSION)
Unknown
Unknown
ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATORVASTATIN CALCIUM; EZETIMIBE
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
ATORVASTATIN CALCIUM; EZETIMIBE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THENALIDINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity; Pruritus
Histamine H1 receptor antagonist
THENALIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
6U94N2D00F
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2S
Molecular Weight:
286.44
AlogP:
3.85
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SALMONELLA TYPHI
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SALMONELLA TYPHI
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IC51
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IC51
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELENOMETHIONINE SE-75
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
SELENOMETHIONINE SE-75
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISOFLAVONE
4
Small molecule
Approved
Unknown
Unknown
Adenocarcinoma of Lung; Head and Neck Neoplasms; Prostatic Neoplasms, Castration-Resistant; Renal Insufficiency, Chronic; Breast Neoplasms; Menopause
Unknown
ISOFLAVONE
×
Maximum Phase:
4
First Approval:
None
UNII:
OVO2KUW8H8
Molecule Type:
Small molecule
Molecular Formula:
C15H10O2
Molecular Weight:
222.24
AlogP:
3.46
PSA:
30.21
HBD:
0.0
HBA:
#RotB:
1.0
Source:
PRAJMALIUM BITARTRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PRAJMALIUM BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
H671L9190Z
Molecule Type:
Small molecule
Molecular Formula:
C27H38N2O8
Molecular Weight:
518.61
AlogP:
2.48
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
URAPIDIL
4
Small molecule
Approved
Unknown
Unknown
Hypertension; Pre-Eclampsia; Stroke
Unknown
URAPIDIL
×
Maximum Phase:
4
First Approval:
None
UNII:
A78GF17HJS
Molecule Type:
Small molecule
Molecular Formula:
C20H29N5O3
Molecular Weight:
387.48
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PROTIONAMIDE
4
Small molecule
Approved
Unknown
Unknown
Tuberculosis
Unknown
PROTIONAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
76YOO33643
Molecule Type:
Small molecule
Molecular Formula:
C9H12N2S
Molecular Weight:
180.28
AlogP:
1.67
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DEXKETOPROFEN
4
Small molecule
Approved
Unknown
Unknown
Pain; Arthralgia; Myalgia; Rheumatic Diseases
Cyclooxygenase inhibitor
DEXKETOPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
6KD9E78X68
Molecule Type:
Small molecule
Molecular Formula:
C16H14O3
Molecular Weight:
254.29
AlogP:
3.11
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VON WILLEBRAND FACTOR HUMAN
4
Unknown
Approved
Unknown
Unknown
Postpartum Hemorrhage; von Willebrand Diseases; Hemorrhage
Unknown
VON WILLEBRAND FACTOR HUMAN
×
Maximum Phase:
4
First Approval:
None
UNII:
ZE22NE22F1
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIVOTIF
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
VIVOTIF
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXYPERTINE
4
Small molecule
Approved
Unknown
Unknown
Psychotic Disorders
Unknown
OXYPERTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
5JGL4G25R7
Molecule Type:
Small molecule
Molecular Formula:
C23H29N3O2
Molecular Weight:
379.5
AlogP:
3.86
PSA:
40.73
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PYRANTEL
4
Small molecule
Approved
Unknown
Unknown
Helminthiasis
Unknown
PYRANTEL
×
Maximum Phase:
4
First Approval:
None
UNII:
4QIH0N49E7
Molecule Type:
Small molecule
Molecular Formula:
C11H14N2S
Molecular Weight:
206.31
AlogP:
2.5
PSA:
15.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
1
2
…
266
267
268
269
270
271
272
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA